Insights from an advisory board: Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency

Keyphrases

• Transitional Care 100%
• Growth Hormone Deficiency 100%
• Brain Cancer 100%
• Cancer Survivors 100%
• Adulthood 100%
• Advisory Board 100%
• Growth Hormone Treatment 60%
• Pediatric 40%
• In Cancer 40%
• Healthcare Providers 40%
• Childhood Cancer Survivors 40%
• Growth Hormone 40%
• Continuity of Care 40%
• Hormone Administration 40%
• Health Benefits 20%
• Transition to Adulthood 20%
• Cancer Treatment 20%
• Recurrence Risk 20%
• Patient Engagement 20%
• Endocrinology 20%
• Comorbidity 20%
• Long-term Growth 20%
• Oncologists 20%
• Tumor Recurrence 20%
• Patient Journey 20%
• Inpatient Treatment 20%
• Treatment Gap 20%
• Transition to Adult Care 20%
• Disease-related 20%
• Treatment Team 20%
• Endocrinologists 20%
• Challenges Faced 20%
• Unique Challenge 20%
• Loss-to-follow-up 20%
• Oncology Care Providers 20%

Medicine and Dentistry

• Pediatrics 100%
• Brain Cancer 100%
• Growth Hormone Deficiency 100%
• Growth Hormone 100%
• Malignant Neoplasm 40%
• Childhood Cancer 40%
• Patient Care 40%
• Oncology 20%
• Cancer Therapy 20%
• Endocrinology 20%
• Patient Referral 20%
• Recurrence Risk 20%
• Tumor Recurrence 20%
• Endocrinologist 20%
• Oncologist 20%
• Transitional Care 20%
• Transition to Adult Care 20%
• Comorbidity 20%
• Endocrine Therapy 20%
• Hormone Replacement Therapy 20%
• Diseases 20%
• Education 20%

Nursing and Health Professions

• Growth Hormone 100%
• Pediatrics 100%
• Growth Hormone Deficiency 100%
• Brain Cancer 100%
• Malignant Neoplasm 40%
• Childhood Cancer 40%
• Patient Care 40%
• Oncologist 20%
• Cancer Therapy 20%
• Transitional Care 20%
• Patient Referral 20%
• Recurrence Risk 20%
• Tumor Recurrence 20%
• Substitution Therapy 20%
• Transition to Adult Care 20%
• Comorbidity 20%
• Diseases 20%
• Endocrinologist 20%
• Education 20%